Calcium channel blockers (versus unexposed)

Early intrauterine death (< 22 weeks)

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S13987
R54921
Weber-Schoendorfer - Calcium blockers, 2008 Miscarriage at least 1st trimester prospective cohort unexposed (general population or NOS) Adjustment: Yes Indications Antihypertensive: All hypertensions, any indications or not specified 2.21 [1.39;3.50] 39/268   59/776 98 268
ref
S13969
R54746
Parazzini - Nifedipine, 1998 Spontaneous abortion (before 20 weeks of gestation) 2nd and/or 3rd trimester randomized controlled trial unexposed, sick Adjustment: Randomisation Indications Antihypertensive: All hypertensions, any indications or not specified 0.19 [0.01;4.05] C 0/132   2/129 2 132
ref
Total 2 studies 1.06 [0.12;9.51] 100 400
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Weber-Schoendorfer - Calcium blockers, 2008Weber-Schoendorfer - Calcium blockers, 2008 2.21[1.39; 3.50]9826870%ROB confusion: seriousROB selection: moderateROB classification: moderateROB missing: moderateROB mesure: unclearROB reporting: moderate Parazzini - Nifedipine, 1998Parazzini - Nifedipine, 1998 0.19[0.01; 4.05]213230%ROB confusion: lowROB selection: unclearROB classification: moderateROB missing: lowROB mesure: moderateROB reporting: moderate Total (2 studies) I2 = 59% 1.06[0.12; 9.51]1004000.05.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 2.21[1.39; 3.51]98268 -NAWeber-Schoendorfer - Calcium blockers, 2008 1 case control studiescase control studies 0 RCTRCT 0.19[0.01; 4.05]2132 -NAParazzini - Nifedipine, 1998 1 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 2.21[1.39; 3.51]98268 -NAWeber-Schoendorfer - Calcium blockers, 2008 1 unexposed, sickunexposed, sick 0.19[0.01; 4.05]2132 -NAParazzini - Nifedipine, 1998 1 Tags Adjustment   - Randomisation  - Randomisation 0.19[0.01; 4.05]2132 -NAParazzini - Nifedipine, 1998 1   - Yes  - Yes 2.21[1.39; 3.51]98268 -NAWeber-Schoendorfer - Calcium blockers, 2008 1 Indications Antihypertensive   - All hypertensions, any indications ...  - All hypertensions, any indications or not specified 1.06[0.12; 9.51]10040059%NAWeber-Schoendorfer - Calcium blockers, 2008 Parazzini - Nifedipine, 1998 2 All studiesAll studies 1.06[0.12; 9.51]10040059%NAWeber-Schoendorfer - Calcium blockers, 2008 Parazzini - Nifedipine, 1998 20.05.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 2.21[1.39; 3.51]98268 -NAWeber-Schoendorfer - Calcium blockers, 2008 1 unexposed, sick controlsunexposed, sick controls Out of scale0.19[0.01; 4.05]2132 -NAParazzini - Nifedipine, 1998 10.510.01.0